{"url_path":"/sec/byah/10-k/2026/item-11","section_key":"item-11","section_title":"Item 11 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**","topic":"sec","document":{"doc_type":"20-F/A","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","accession_number":"0001213900-26-057152","cik":"0001986247","ticker":"BYAH","issuer_name":"Park Ha Biological Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","primary_entity_key":"0001986247","primary_entity_name":"Park Ha Biological Technology Co., Ltd."},"word_count":150,"has_tables":true,"body_markdown":"**ITEM\n11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**\n\n \n\nFinancial\ninstruments that potentially subject the Company to concentration of credit risk are cash, and accounts receivable arising from its normal\nbusiness activities. The Company places its cash in what it believes to be credit-worthy financial institutions or trading platforms.\n\n \n\nThe\nCompany conducts credit evaluations of customers, and generally does not require collateral or other security from its customers. The\nCompany establishes an allowance for expected credit losses primarily based upon the factors surrounding the credit risk of specific\ncustomers.\n\n \n\nForeign\ncurrency exchange rate risk\n\n \n\nThe\nfunctional currency and the reporting currency of the Company are RMB and U.S. dollars, respectively. The Company’s exposure to\nforeign currency exchange rate risk primarily relates to cash, accounts receivable and accounts payable. Any significant fluctuation\nof RMB against U.S. dollars may materially and adversely affect the Company’s cash flows, revenues, earnings and financial positions."}